Pfizer: Sharpening Their Scalpels

is a sidebar to , a story that will be featured in the next issue of Forbes. Investors hope Pfizer���s parts could fetch $180 billion, 11% more than the current value. Possible Value: $8 billion The $60 billion acquisition of Wyeth gave Pfizer a $1.9...